Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis

被引:0
|
作者
Wenzhe Li
Huailei Ma
Jin Zhang
Ling Zhu
Chen Wang
Yanlian Yang
机构
[1] CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety,CAS Key Laboratory of Standardization and Measurement for Nanotechnology
[2] CAS Center for Excellence in Nanoscience,Academy for Advanced Interdisciplinary Studies
[3] National Center for Nanoscience and Technology,undefined
[4] Peking University,undefined
[5] University of Chinese Academy of Sciences,undefined
[6] 19 A Yuquan Rd,undefined
[7] Shijingshan District,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
引用
收藏
相关论文
共 50 条
  • [1] Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
    Li, Wenzhe
    Ma, Huailei
    Zhang, Jin
    Zhu, Ling
    Wang, Chen
    Yang, Yanlian
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [2] Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
    Wenzhe Li
    Huailei Ma
    Jin Zhang
    Ling Zhu
    Chen Wang
    Yanlian Yang
    [J]. Scientific Reports, 7
  • [3] Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis (vol 7, 2017)
    Li, Wenzhe
    Ma, Huailei
    Zhang, Jin
    Zhu, Ling
    Wang, Chen
    Yang, Yanlian
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [4] Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
    de Beca, Francisco Ferro
    Caetano, Pedro
    Gerhard, Rene
    Alvarenga, Cesar Augusto
    Gomes, Madalena
    Paredes, Joana
    Schmitt, Fernando
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (03) : 187 - 191
  • [5] Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
    Ricardo, Sara
    Vieira, Andre Filipe
    Gerhard, Rene
    Leitao, Dina
    Pinto, Regina
    Cameselle-Teijeiro, Jorge F.
    Milanezi, Fernanda
    Schmitt, Fernando
    Paredes, Joana
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (11) : 937 - 946
  • [6] Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
    Horimoto, Yoshiya
    Arakawa, Atsushi
    Sasahara, Noriko
    Tanabe, Masahiko
    Sai, Sei
    Himuro, Takanori
    Saito, Mitsue
    [J]. PLOS ONE, 2016, 11 (10):
  • [7] Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma
    Han, Sang-Ah
    Jang, Jae Hoon
    Won, Kyu Yeoun
    Lim, Sung-Jig
    Song, Jeong-Yoon
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (08) : 956 - 963
  • [8] CANCER STEM CELLS CHARACTERIZATION IN INVASIVE BREAST CARCINOMAS THROUGH CD44, CD24 AND ALDH1 EXPRESSION
    Ricardo, S.
    Vieira, A.
    Milanezi, F.
    Cameselle, J.
    Schmitt, F.
    Paredes, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 28 - 29
  • [9] The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast CD44/CD24 expression in breast cancer
    Kapucuoglu, Nilgun
    Bozkurt, Kemal Kursat
    Baspinar, Sirin
    Kocer, Murat
    Eroglu, Hasan Erol
    Akdeniz, Rasit
    Akcil, Mehtap
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (10) : 740 - 747
  • [10] Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
    Jaggupilli, Appalaraju
    Elkord, Eyad
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,